LYZ and inflammatory bowel disease: Given that the pathogenesis of IBD is driven by pathogenic immune responses to gut microbiota, we analyzed the intestinal microbiota using the T-RFLP method to evaluate the mitigating effects of ESM and its major component LYZ in a DSS-induced colitis model.